M&A Deal Summary |
|
|---|---|
| Date | 2017-07-24 |
| Target | Symplmed Pharmaceuticals - DyrctAxess |
| Sector | Information Technology |
| Buyer(s) | Adhera Therapeutics |
| Sellers(s) | Symplmed Pharmaceuticals |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1983 |
| Sector | Life Science |
| Revenue | 680K USD (2015) |
Adhera Therapeutics, Inc. is an oligonucleotide therapeutics company with broad drug discovery technologies providing the ability to develop proprietary single and double-stranded nucleic acid therapeutics including siRNAs, microRNA mimics, antagomirs, and antisense compounds, including messenger RNA therapeutics. These technologies were built via a roll-up strategy to discover and develop different types of nucleic acid therapeutics in order to modulate (up or down) a specific protein(s) which is either being produced too much or too little thereby causing a particular disease.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Information Technology M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 2 of 2 |
| State: Ohio M&A | 1 of 1 |
| Country: United States M&A | 2 of 2 |
| Year: 2017 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-05-03 |
Turing Pharmaceuticals - Intranasal Ketamine Program
New York, New York, United States Turing Pharmaceuticals - Intranasal Ketamine Program comprises business of developing intranasal ketamine to treat disorders due to stress. The asset is located in the United States. |
Buy | - |
Symplmed Pharmaceuticals, Inc. is a private pharmaceutical company optimizing the value of its medicines and those of its industry partners by streamlining the prescription process, from fulfillment and payment to therapeutic compliance and outcomes monitoring. The Company's patented technology platform, DyrctAxess™, enables direct delivery of medications to a patient's home and addresses the problem of unfilled prescriptions. Symplmed is taking a therapeutic area approach, ensuring that medications necessary to manage a particular disease state are available through its DyrctAxess platform.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Information Technology M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: Ohio M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2017 M&A | 1 of 1 |
